SHREYASKUMAR PATEL to Confidence Intervals
This is a "connection" page, showing publications SHREYASKUMAR PATEL has written about Confidence Intervals.
Connection Strength
0.145
-
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. Lancet Oncol. 2017 11; 18(11):1493-1501.
Score: 0.131
-
Angiosarcoma of the breast. Cancer. 2005 Dec 15; 104(12):2682-8.
Score: 0.014